Page last updated: 2024-08-17

spironolactone and 8-hydroxy-2'-deoxyguanosine

spironolactone has been researched along with 8-hydroxy-2'-deoxyguanosine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koda, M; Matono, T; Murawaki, Y; Sugihara, T; Tokunaga, S; Ueki, M1
Ando, K; Fujita, M; Fujita, T; Kawarazaki, H; Matsui, H; Nagae, A1
Amann, K; Brand, S; Mandel, P; Schupp, N; Zimnol, A1
Hayashi, S; Ishizuka, A; Iwashima, Y; Kawano, Y; Kishida, M; Nakamura, S; Ohta, Y; Yoshihara, F1
Barrera-Chimal, J; Bobadilla, NA; Espinoza, R; González, N; González-Bobadilla, Y; Juárez, H; Marino, LA; Morales-Buenrostro, LE; Ortega-Trejo, JA; Pérez-Villalva, R; Zamora-Mejía, FM1

Trials

2 trial(s) available for spironolactone and 8-hydroxy-2'-deoxyguanosine

ArticleYear
Effects of a selective aldosterone blocker and thiazide-type diuretic on blood pressure and organ damage in hypertensive patients.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2015, Volume: 37, Issue:7

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Deoxyguanosine; Diuretics; Eplerenone; Female; Glomerular Filtration Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Pulse Wave Analysis; Spironolactone; Treatment Outcome; Uric Acid

2015
Spironolactone reduces oxidative stress in living donor kidney transplantation: a randomized controlled trial.
    American journal of physiology. Renal physiology, 2019, 09-01, Volume: 317, Issue:3

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Antioxidants; Biomarkers; Double-Blind Method; Female; HSP72 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipocalin-2; Living Donors; Male; Mexico; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Pilot Projects; Spironolactone; Time Factors; Treatment Outcome; Young Adult

2019

Other Studies

3 other study(ies) available for spironolactone and 8-hydroxy-2'-deoxyguanosine

ArticleYear
The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat.
    International journal of molecular medicine, 2010, Volume: 25, Issue:6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Bile Ducts; Deoxyguanosine; Eplerenone; Gene Expression Regulation; Hydroxyproline; Immunohistochemistry; Ligation; Lipid Peroxidation; Liver Cirrhosis; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Spironolactone

2010
Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:9

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Cyclic N-Oxides; Deoxyguanosine; Eplerenone; Hydralazine; Hypertension; Kidney; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Dahl; Receptors, Mineralocorticoid; Renal Insufficiency; Sodium Chloride, Dietary; Spin Labels; Spironolactone

2010
Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.
    PloS one, 2014, Volume: 9, Issue:12

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Deoxyguanosine; DNA Damage; DNA Repair; Enzyme Activation; Eplerenone; Guanosine; Heart; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Spin Labels; Spironolactone; Tetrazoles

2014